nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—OPRM1—nicotine dependence	0.815	1	CbGaD
Oxycodone—Electrocardiogram ST segment depression—Varenicline—nicotine dependence	0.00768	0.0548	CcSEcCtD
Oxycodone—Withdrawal symptom—Varenicline—nicotine dependence	0.00425	0.0303	CcSEcCtD
Oxycodone—Dysphoria—Varenicline—nicotine dependence	0.00403	0.0288	CcSEcCtD
Oxycodone—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00356	0.0254	CcSEcCtD
Oxycodone—Balance disorder—Varenicline—nicotine dependence	0.00319	0.0228	CcSEcCtD
Oxycodone—Intestinal obstruction—Varenicline—nicotine dependence	0.00256	0.0183	CcSEcCtD
Oxycodone—Gingivitis—Varenicline—nicotine dependence	0.00222	0.0159	CcSEcCtD
Oxycodone—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0022	0.0677	CbGpPWpGaD
Oxycodone—Mydriasis—Varenicline—nicotine dependence	0.00219	0.0156	CcSEcCtD
Oxycodone—Rhinorrhoea—Varenicline—nicotine dependence	0.00215	0.0154	CcSEcCtD
Oxycodone—Endocrine disorder—Varenicline—nicotine dependence	0.0021	0.015	CcSEcCtD
Oxycodone—Chest discomfort—Varenicline—nicotine dependence	0.00197	0.0141	CcSEcCtD
Oxycodone—Accidental injury—Varenicline—nicotine dependence	0.00197	0.0141	CcSEcCtD
Oxycodone—Thinking abnormal—Varenicline—nicotine dependence	0.00191	0.0136	CcSEcCtD
Oxycodone—Lacrimation increased—Varenicline—nicotine dependence	0.00189	0.0135	CcSEcCtD
Oxycodone—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00182	0.0561	CbGpPWpGaD
Oxycodone—Galantamine—CHRNB3—nicotine dependence	0.0018	0.148	CrCbGaD
Oxycodone—Blood pressure increased—Varenicline—nicotine dependence	0.00174	0.0124	CcSEcCtD
Oxycodone—Abnormal dreams—Varenicline—nicotine dependence	0.00172	0.0123	CcSEcCtD
Oxycodone—Eructation—Varenicline—nicotine dependence	0.00171	0.0122	CcSEcCtD
Oxycodone—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00159	0.0489	CbGpPWpGaD
Oxycodone—Urine output increased—Varenicline—nicotine dependence	0.00158	0.0113	CcSEcCtD
Oxycodone—Hypertonia—Varenicline—nicotine dependence	0.00153	0.0109	CcSEcCtD
Oxycodone—Mental disability—Varenicline—nicotine dependence	0.00151	0.0108	CcSEcCtD
Oxycodone—Euphoric mood—Varenicline—nicotine dependence	0.0015	0.0107	CcSEcCtD
Oxycodone—Lymphadenopathy—Varenicline—nicotine dependence	0.00148	0.0106	CcSEcCtD
Oxycodone—Polyuria—Varenicline—nicotine dependence	0.00144	0.0103	CcSEcCtD
Oxycodone—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00142	0.0438	CbGpPWpGaD
Oxycodone—Disorientation—Varenicline—nicotine dependence	0.00142	0.0101	CcSEcCtD
Oxycodone—Injury—Varenicline—nicotine dependence	0.00138	0.00983	CcSEcCtD
Oxycodone—Galantamine—CHRNA6—nicotine dependence	0.00137	0.112	CrCbGaD
Oxycodone—Libido decreased—Varenicline—nicotine dependence	0.00137	0.00974	CcSEcCtD
Oxycodone—Amnesia—Varenicline—nicotine dependence	0.00135	0.00962	CcSEcCtD
Oxycodone—Increased appetite—Varenicline—nicotine dependence	0.00135	0.00962	CcSEcCtD
Oxycodone—Thirst—Varenicline—nicotine dependence	0.00133	0.00949	CcSEcCtD
Oxycodone—Arthritis—Varenicline—nicotine dependence	0.0013	0.0093	CcSEcCtD
Oxycodone—Hypoglycaemia—Varenicline—nicotine dependence	0.0013	0.00926	CcSEcCtD
Oxycodone—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00126	0.00896	CcSEcCtD
Oxycodone—Migraine—Varenicline—nicotine dependence	0.00125	0.00889	CcSEcCtD
Oxycodone—Affect lability—Varenicline—nicotine dependence	0.00125	0.00889	CcSEcCtD
Oxycodone—Irritability—Varenicline—nicotine dependence	0.00121	0.00862	CcSEcCtD
Oxycodone—Urinary retention—Varenicline—nicotine dependence	0.0012	0.00859	CcSEcCtD
Oxycodone—Mood swings—Varenicline—nicotine dependence	0.0012	0.00856	CcSEcCtD
Oxycodone—Galantamine—CHRNA5—nicotine dependence	0.00116	0.0954	CrCbGaD
Oxycodone—Dry skin—Varenicline—nicotine dependence	0.00116	0.00828	CcSEcCtD
Oxycodone—Abdominal pain upper—Varenicline—nicotine dependence	0.00116	0.00825	CcSEcCtD
Oxycodone—Breast disorder—Varenicline—nicotine dependence	0.00114	0.00817	CcSEcCtD
Oxycodone—Nasopharyngitis—Varenicline—nicotine dependence	0.00113	0.00808	CcSEcCtD
Oxycodone—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00113	0.0348	CbGpPWpGaD
Oxycodone—Gastritis—Varenicline—nicotine dependence	0.00112	0.008	CcSEcCtD
Oxycodone—Abdominal distension—Varenicline—nicotine dependence	0.0011	0.00786	CcSEcCtD
Oxycodone—Asthma—Varenicline—nicotine dependence	0.00109	0.00781	CcSEcCtD
Oxycodone—Dysphagia—Varenicline—nicotine dependence	0.00109	0.00781	CcSEcCtD
Oxycodone—Galantamine—CHRNA10—nicotine dependence	0.00109	0.0897	CrCbGaD
Oxycodone—Bronchitis—Varenicline—nicotine dependence	0.00105	0.00751	CcSEcCtD
Oxycodone—Erectile dysfunction—Varenicline—nicotine dependence	0.00101	0.00719	CcSEcCtD
Oxycodone—Photosensitivity reaction—Varenicline—nicotine dependence	0.000999	0.00713	CcSEcCtD
Oxycodone—Hyperglycaemia—Varenicline—nicotine dependence	0.000987	0.00704	CcSEcCtD
Oxycodone—Infestation NOS—Varenicline—nicotine dependence	0.000976	0.00696	CcSEcCtD
Oxycodone—Infestation—Varenicline—nicotine dependence	0.000976	0.00696	CcSEcCtD
Oxycodone—Stomatitis—Varenicline—nicotine dependence	0.000951	0.00679	CcSEcCtD
Oxycodone—Hepatobiliary disease—Varenicline—nicotine dependence	0.000923	0.00659	CcSEcCtD
Oxycodone—Epistaxis—Varenicline—nicotine dependence	0.000921	0.00657	CcSEcCtD
Oxycodone—Sinusitis—Varenicline—nicotine dependence	0.000916	0.00653	CcSEcCtD
Oxycodone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000914	0.0281	CbGpPWpGaD
Oxycodone—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000902	0.0277	CbGpPWpGaD
Oxycodone—Bradycardia—Varenicline—nicotine dependence	0.000892	0.00636	CcSEcCtD
Oxycodone—Hallucination—Varenicline—nicotine dependence	0.000872	0.00622	CcSEcCtD
Oxycodone—Hypoaesthesia—Varenicline—nicotine dependence	0.000872	0.00622	CcSEcCtD
Oxycodone—Urinary tract disorder—Varenicline—nicotine dependence	0.000865	0.00617	CcSEcCtD
Oxycodone—Oedema peripheral—Varenicline—nicotine dependence	0.000863	0.00616	CcSEcCtD
Oxycodone—Connective tissue disorder—Varenicline—nicotine dependence	0.000861	0.00614	CcSEcCtD
Oxycodone—Urethral disorder—Varenicline—nicotine dependence	0.000859	0.00613	CcSEcCtD
Oxycodone—Visual impairment—Varenicline—nicotine dependence	0.000844	0.00602	CcSEcCtD
Oxycodone—Eye disorder—Varenicline—nicotine dependence	0.000819	0.00584	CcSEcCtD
Oxycodone—Tinnitus—Varenicline—nicotine dependence	0.000817	0.00583	CcSEcCtD
Oxycodone—Cardiac disorder—Varenicline—nicotine dependence	0.000813	0.0058	CcSEcCtD
Oxycodone—Angiopathy—Varenicline—nicotine dependence	0.000795	0.00567	CcSEcCtD
Oxycodone—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000793	0.0244	CbGpPWpGaD
Oxycodone—Immune system disorder—Varenicline—nicotine dependence	0.000791	0.00565	CcSEcCtD
Oxycodone—Mediastinal disorder—Varenicline—nicotine dependence	0.00079	0.00563	CcSEcCtD
Oxycodone—Chills—Varenicline—nicotine dependence	0.000786	0.00561	CcSEcCtD
Oxycodone—Galantamine—CHRNB4—nicotine dependence	0.000786	0.0645	CrCbGaD
Oxycodone—Mental disorder—Varenicline—nicotine dependence	0.000768	0.00548	CcSEcCtD
Oxycodone—Malnutrition—Varenicline—nicotine dependence	0.000763	0.00544	CcSEcCtD
Oxycodone—Flatulence—Varenicline—nicotine dependence	0.000752	0.00536	CcSEcCtD
Oxycodone—Dysgeusia—Varenicline—nicotine dependence	0.000747	0.00533	CcSEcCtD
Oxycodone—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000746	0.023	CbGpPWpGaD
Oxycodone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000741	0.0228	CbGpPWpGaD
Oxycodone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000739	0.0227	CbGpPWpGaD
Oxycodone—Back pain—Varenicline—nicotine dependence	0.000738	0.00526	CcSEcCtD
Oxycodone—Muscle spasms—Varenicline—nicotine dependence	0.000733	0.00523	CcSEcCtD
Oxycodone—Galantamine—CHRNB2—nicotine dependence	0.000719	0.059	CrCbGaD
Oxycodone—Tremor—Varenicline—nicotine dependence	0.000715	0.0051	CcSEcCtD
Oxycodone—Ill-defined disorder—Varenicline—nicotine dependence	0.000708	0.00505	CcSEcCtD
Oxycodone—Anaemia—Varenicline—nicotine dependence	0.000705	0.00503	CcSEcCtD
Oxycodone—Agitation—Varenicline—nicotine dependence	0.000701	0.005	CcSEcCtD
Oxycodone—Angioedema—Varenicline—nicotine dependence	0.000697	0.00497	CcSEcCtD
Oxycodone—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000695	0.0214	CbGpPWpGaD
Oxycodone—Malaise—Varenicline—nicotine dependence	0.000688	0.00491	CcSEcCtD
Oxycodone—Vertigo—Varenicline—nicotine dependence	0.000685	0.00489	CcSEcCtD
Oxycodone—Syncope—Varenicline—nicotine dependence	0.000684	0.00488	CcSEcCtD
Oxycodone—Palpitations—Varenicline—nicotine dependence	0.000674	0.00481	CcSEcCtD
Oxycodone—Loss of consciousness—Varenicline—nicotine dependence	0.00067	0.00478	CcSEcCtD
Oxycodone—Cough—Varenicline—nicotine dependence	0.000666	0.00475	CcSEcCtD
Oxycodone—Convulsion—Varenicline—nicotine dependence	0.000661	0.00471	CcSEcCtD
Oxycodone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00066	0.0203	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000654	0.0201	CbGpPWpGaD
Oxycodone—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000652	0.02	CbGpPWpGaD
Oxycodone—Chest pain—Varenicline—nicotine dependence	0.000649	0.00463	CcSEcCtD
Oxycodone—Arthralgia—Varenicline—nicotine dependence	0.000649	0.00463	CcSEcCtD
Oxycodone—Myalgia—Varenicline—nicotine dependence	0.000649	0.00463	CcSEcCtD
Oxycodone—Anxiety—Varenicline—nicotine dependence	0.000647	0.00462	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000645	0.0046	CcSEcCtD
Oxycodone—Discomfort—Varenicline—nicotine dependence	0.000642	0.00458	CcSEcCtD
Oxycodone—Dry mouth—Varenicline—nicotine dependence	0.000635	0.00453	CcSEcCtD
Oxycodone—Oedema—Varenicline—nicotine dependence	0.000622	0.00444	CcSEcCtD
Oxycodone—Infection—Varenicline—nicotine dependence	0.000618	0.00441	CcSEcCtD
Oxycodone—Shock—Varenicline—nicotine dependence	0.000612	0.00437	CcSEcCtD
Oxycodone—Nervous system disorder—Varenicline—nicotine dependence	0.00061	0.00436	CcSEcCtD
Oxycodone—Tachycardia—Varenicline—nicotine dependence	0.000607	0.00433	CcSEcCtD
Oxycodone—Skin disorder—Varenicline—nicotine dependence	0.000605	0.00431	CcSEcCtD
Oxycodone—Hyperhidrosis—Varenicline—nicotine dependence	0.000602	0.00429	CcSEcCtD
Oxycodone—Methylnaltrexone—OPRM1—nicotine dependence	0.000601	0.0493	CrCbGaD
Oxycodone—Anorexia—Varenicline—nicotine dependence	0.000593	0.00423	CcSEcCtD
Oxycodone—Hypotension—Varenicline—nicotine dependence	0.000582	0.00415	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000567	0.00405	CcSEcCtD
Oxycodone—Insomnia—Varenicline—nicotine dependence	0.000563	0.00402	CcSEcCtD
Oxycodone—Dyspnoea—Varenicline—nicotine dependence	0.000555	0.00396	CcSEcCtD
Oxycodone—Somnolence—Varenicline—nicotine dependence	0.000553	0.00395	CcSEcCtD
Oxycodone—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000553	0.017	CbGpPWpGaD
Oxycodone—Nalbuphine—OPRM1—nicotine dependence	0.00055	0.0451	CrCbGaD
Oxycodone—Dyspepsia—Varenicline—nicotine dependence	0.000548	0.00391	CcSEcCtD
Oxycodone—Galantamine—CHRNA3—nicotine dependence	0.000545	0.0447	CrCbGaD
Oxycodone—Decreased appetite—Varenicline—nicotine dependence	0.000541	0.00386	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000537	0.00383	CcSEcCtD
Oxycodone—Fatigue—Varenicline—nicotine dependence	0.000537	0.00383	CcSEcCtD
Oxycodone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000535	0.0165	CbGpPWpGaD
Oxycodone—Constipation—Varenicline—nicotine dependence	0.000532	0.0038	CcSEcCtD
Oxycodone—Pain—Varenicline—nicotine dependence	0.000532	0.0038	CcSEcCtD
Oxycodone—Feeling abnormal—Varenicline—nicotine dependence	0.000513	0.00366	CcSEcCtD
Oxycodone—Dihydrocodeine—OPRM1—nicotine dependence	0.000511	0.0419	CrCbGaD
Oxycodone—Gastrointestinal pain—Varenicline—nicotine dependence	0.000509	0.00363	CcSEcCtD
Oxycodone—Urticaria—Varenicline—nicotine dependence	0.000494	0.00353	CcSEcCtD
Oxycodone—Body temperature increased—Varenicline—nicotine dependence	0.000492	0.00351	CcSEcCtD
Oxycodone—Abdominal pain—Varenicline—nicotine dependence	0.000492	0.00351	CcSEcCtD
Oxycodone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00047	0.0144	CbGpPWpGaD
Oxycodone—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000463	0.0143	CbGpPWpGaD
Oxycodone—Hypersensitivity—Varenicline—nicotine dependence	0.000459	0.00327	CcSEcCtD
Oxycodone—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000452	0.0139	CbGpPWpGaD
Oxycodone—Oxymorphone—OPRM1—nicotine dependence	0.000448	0.0368	CrCbGaD
Oxycodone—Naltrexone—OPRM1—nicotine dependence	0.000448	0.0368	CrCbGaD
Oxycodone—Asthenia—Varenicline—nicotine dependence	0.000447	0.00319	CcSEcCtD
Oxycodone—Pruritus—Varenicline—nicotine dependence	0.00044	0.00314	CcSEcCtD
Oxycodone—Ethylmorphine—OPRM1—nicotine dependence	0.000428	0.0351	CrCbGaD
Oxycodone—Diarrhoea—Varenicline—nicotine dependence	0.000426	0.00304	CcSEcCtD
Oxycodone—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000417	0.0128	CbGpPWpGaD
Oxycodone—Dizziness—Varenicline—nicotine dependence	0.000412	0.00294	CcSEcCtD
Oxycodone—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000396	0.0122	CbGpPWpGaD
Oxycodone—Vomiting—Varenicline—nicotine dependence	0.000396	0.00282	CcSEcCtD
Oxycodone—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.000393	0.0121	CbGpPWpGaD
Oxycodone—Rash—Varenicline—nicotine dependence	0.000392	0.0028	CcSEcCtD
Oxycodone—Dermatitis—Varenicline—nicotine dependence	0.000392	0.0028	CcSEcCtD
Oxycodone—Hydrocodone—OPRM1—nicotine dependence	0.000392	0.0321	CrCbGaD
Oxycodone—Headache—Varenicline—nicotine dependence	0.00039	0.00278	CcSEcCtD
Oxycodone—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000388	0.0119	CbGpPWpGaD
Oxycodone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000381	0.0117	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000373	0.0115	CbGpPWpGaD
Oxycodone—Nausea—Varenicline—nicotine dependence	0.00037	0.00264	CcSEcCtD
Oxycodone—Codeine—OPRM1—nicotine dependence	0.000341	0.028	CrCbGaD
Oxycodone—Galantamine—CHRNA4—nicotine dependence	0.000337	0.0276	CrCbGaD
Oxycodone—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000335	0.0103	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000327	0.0101	CbGpPWpGaD
Oxycodone—Naloxone—OPRM1—nicotine dependence	0.000327	0.0268	CrCbGaD
Oxycodone—Hydromorphone—OPRM1—nicotine dependence	0.000325	0.0266	CrCbGaD
Oxycodone—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000315	0.00967	CbGpPWpGaD
Oxycodone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000307	0.00944	CbGpPWpGaD
Oxycodone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000303	0.00932	CbGpPWpGaD
Oxycodone—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000302	0.00928	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000292	0.00898	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000284	0.00875	CbGpPWpGaD
Oxycodone—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00028	0.00863	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000276	0.00848	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000256	0.00787	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000255	0.00785	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00025	0.00769	CbGpPWpGaD
Oxycodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000249	0.00765	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000232	0.00713	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000227	0.00699	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000224	0.00689	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000219	0.00675	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000215	0.0066	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000211	0.00649	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000203	0.00625	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000202	0.00622	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.0002	0.00616	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000199	0.00613	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000199	0.00613	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.00019	0.00586	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000189	0.00582	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000185	0.00569	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000182	0.0056	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000181	0.00556	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000176	0.0054	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000172	0.00528	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000169	0.00518	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000167	0.00514	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.00016	0.00491	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000159	0.00488	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000156	0.00481	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000148	0.00457	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00014	0.00431	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000138	0.00424	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000137	0.00421	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000135	0.00415	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000134	0.00412	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000132	0.00407	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00013	0.00401	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000121	0.00371	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.00012	0.00369	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000108	0.00331	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGD1—nicotine dependence	0.000107	0.00331	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000102	0.00314	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000102	0.00312	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	9.78e-05	0.00301	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	9.49e-05	0.00292	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	9.44e-05	0.0029	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGD1—nicotine dependence	9.43e-05	0.0029	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	8.57e-05	0.00264	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	8.33e-05	0.00256	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGD1—nicotine dependence	7.97e-05	0.00245	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	7.78e-05	0.00239	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	7.07e-05	0.00217	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	7.04e-05	0.00216	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	6.82e-05	0.0021	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP2A7—nicotine dependence	6.73e-05	0.00207	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—WASF2—nicotine dependence	6.69e-05	0.00206	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—WASF1—nicotine dependence	6.41e-05	0.00197	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	6.2e-05	0.00191	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—WASF2—nicotine dependence	5.87e-05	0.0018	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	5.77e-05	0.00178	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	5.77e-05	0.00177	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—WASF1—nicotine dependence	5.62e-05	0.00173	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	5.24e-05	0.00161	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	5.06e-05	0.00156	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—WASF2—nicotine dependence	4.96e-05	0.00152	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP2A7—nicotine dependence	4.86e-05	0.0015	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—WASF1—nicotine dependence	4.75e-05	0.00146	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—DRD2—nicotine dependence	4.17e-05	0.00128	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—DRD2—nicotine dependence	3.66e-05	0.00113	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.46e-05	0.00106	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DRD2—nicotine dependence	3.09e-05	0.000951	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.26e-05	0.000695	CbGpPWpGaD
